TDOC — Teladoc Health Balance Sheet
0.000.00%
- $1.26bn
- $1.51bn
- $2.57bn
- 61
- 75
- 18
- 51
Annual balance sheet for Teladoc Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 787 | 896 | 918 | 1,124 | 1,298 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 169 | 169 | 236 | 230 | 224 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,060 | 1,225 | 1,315 | 1,489 | 1,664 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 75.2 | 74 | 71.5 | 72.1 | 56.6 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 17,755 | 17,735 | 4,345 | 4,392 | 3,517 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 333 | 331 | 400 | 421 | 942 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,871 | 1,689 | 2,038 | 2,066 | 2,025 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 15,884 | 16,046 | 2,308 | 2,326 | 1,491 |
Total Liabilities & Shareholders' Equity | 17,755 | 17,735 | 4,345 | 4,392 | 3,517 |
Total Common Shares Outstanding |